MedPage Today 
(2/7, Fiore) reports, "Metformin should be the first drug of choice in
oral therapy for type 2 diabetics who don't respond to diet and
lifestyle changes, according to a new guideline
" published Feb. 7 in the Annals of Internal Medicine. "A second agent
can be added if metformin monotherapy fails to control hyperglycemia,
but there's insufficient evidence to recommend one secondary agent over
another," the guideline from the American College of Physicians (ACP)
explains.
(2/7, Fiore) reports, "Metformin should be the first drug of choice in
oral therapy for type 2 diabetics who don't respond to diet and
lifestyle changes, according to a new guideline
" published Feb. 7 in the Annals of Internal Medicine. "A second agent
can be added if metformin monotherapy fails to control hyperglycemia,
but there's insufficient evidence to recommend one secondary agent over
another," the guideline from the American College of Physicians (ACP)
explains.
However, even though "metformin is more effective with fewer side
effects" and costs less, "the ACP is recommending that metformin only be
prescribed after someone has tried to change his or her lifestyle," HealthDay
(2/7, Gordon) reports. HealthDay adds, "There are currently 11
different classes of medications approved by the US Food and Drug
Administration for the treatment of type 2 diabetes, according to the
guidelines."
(2/7, Gordon) reports. HealthDay adds, "There are currently 11
different classes of medications approved by the US Food and Drug
Administration for the treatment of type 2 diabetes, according to the
guidelines."
Reminder that one MUST HAVE Reasonably intact renal function to get metformin
No comments:
Post a Comment